TACTILE SYSTEMS TECHNOLOGY INC (TCMD)
Tactile Systems Technology, Inc. is a medical technology firm that develops and supplies specialized devices to treat chronic health conditions across the United States. Its product portfolio features the Flexitouch Plus system, a pneumatic compression device designed for managing lymphedema. The company also offers the Entre system, a portable pneumatic compression solution for at-home treatment of various venous disorders, including lymphedema, chronic venous insufficiency, and venous leg ulcers. Additionally, Tactile Systems provides the AffloVest, a portable high-frequency chest wall oscillation device used to address retained pulmonary secretions associated with conditions such as bronchiectasis, cystic fibrosis, and certain neuromuscular disorders. Established in 1995, the company maintains its headquarters in Minneapolis, Minnesota.
Sector: Surgical & Medical Instruments & Apparatus
Industry: Medical - Devices
Tactile Systems Technology, Inc.
1-25 of 864 filings
Recent SEC filings with analysis
- 10-QTactile Medical reported Q3 2026 revenue of $91.9 million, up 7% year-over-year, with lymphedema product revenue up 13% offset by a 25% decline in airway…
- 8-KTactile Medical reported Q3 2026 revenue of $91.9 million, up 7% year-over-year, driven by 13% growth in its core lymphedema business — its fifth consecutive…